Vaccine Characteristics

  • Comprises live-attenuated virus.
  • Available globally primarily as combination vaccine containing measles, mumps, and rubella components.
  • Formulated as lyophilized powder requiring reconstitution with sterile diluent.
  • Contains no preservatives.

Available Strains And Brands

  • Various strains developed and utilized globally.
Vaccine BrandMumps Strain UtilizedCell Culture Substrate
TresivacLeningrad-ZagrebChick embryo fibroblast cells
PriorixRIT 4385 (Jeryl Lynn derivative)Chick embryo fibroblasts
ZyVacHoshinoChick fibroblast cells

Dosage And Administration

  • Standard dose measures exactly 0.5 mL.
  • Administered strictly via subcutaneous route.
  • Preferred anatomical injection sites include right upper arm or anterolateral thigh.

Storage Guidelines

  • Maintain strict cold chain between 2°C and 8°C.
  • Protect un-reconstituted and reconstituted vials from light exposure.
  • Reconstituted vaccine loses potency rapidly; discard within 4 to 6 hours to prevent bacterial contamination.

Immunization Schedule

  • Indian Academy Of Pediatrics recommends three-dose schedule utilizing combination vaccine.
  • Universal Immunization Programme currently excludes mumps component, utilizing measles-rubella vaccine instead.
Dose SequenceRecommended Age
First dose9 completed months
Second dose15 to 18 months
Third dose4 to 6 years

Efficacy And Immunogenicity

  • Primary seroconversion rates exceed 90%.
  • Single-dose clinical efficacy measures only 60% to 90%.
  • Single-dose populations experience significant disease outbreaks, necessitating multi-dose schedules for durable protection.

Adverse Effects

  • Fever exceeding 39°C occurs 7 to 12 days post-vaccination in roughly 5% recipients.
  • Transient parotitis occurs rarely.
  • Aseptic meningitis manifests 2 to 3 weeks following administration.
  • Meningitis risk correlates directly with utilized strain (Leningrad-Zagreb carries highest risk, followed by Hoshino, Urabe, and Jeryl Lynn).
  • Vaccine virus demonstrates no transmission from vaccinees to close contacts.
  • Lacks any proven causal relationship with autism, Guillain-Barre syndrome, or inflammatory bowel disease.

Contraindications And Precautions

  • Strictly contraindicated during pregnancy.
  • Avoid in severe immunocompromised states including severe human immunodeficiency virus infection or systemic high-dose corticosteroid therapy.
  • Contraindicated following anaphylactic reactions to prior doses or specific vaccine components.
  • Precaution required for individuals receiving antibody-containing blood products within preceding 3 to 11 months.